Grants & Contracts
-
Principal Investigator, Biomedical Research Support Grant No. 27821:"Genome structure around the a-globin complex and its implications for gene therapy".1988-1989 $ 12,000
-
Principal Investigator, Subcontract from "Center for the Study of Inflammatory Bowel Disease", NIH grant #AM36200 "Isolation and Characterization of the Gene Coding for the Perinuclear Granulocyte Protein Identified by an Ulcerative Colitis Specific Antibody". 1989 $ 7,000
-
Co-Principal Investigator for private donation grant: "Pediatric leukemia research"1991-1993 $ 800,000
-
Principal Investigator, Grant #RO1-DC01402 from the National Institute on Deafness and Communication Disorders: "Molecular basis of maternally transmitted deafness". 1992-1996 $ 930,534
-
Principal Investigator, Clinical Research Grant #6-FY92-0154 from the March of Dimes Birth Defects Foundation: "Molecular basis of sensorineural deafness inherited by the simultaneous involvement of a mitochondrial and nuclear mutation". 1992-1994 $ 60,000
-
Principal Investigator, Women's Health Initiative Supplement for grant #RO1-DC01402 from the NIDCD: "Molecular basis of maternally transmitted deafness". 1993-1994 $ 50,000
-
Principal Investigator, Parker Hughes Leukemia Trust: "Induction of apoptosis as a therapeutic modality for leukemia". 1993-1994 $172,500
-
Principal Investigator, CSMC Young Investigator Award: "Molecular basis of aminoglycosideinduced ototoxicity". 1994-1995 $ 10,000
-
Principal Investigator, Arthritis Foundation: "Molecular basis of Familial Mediterranean Fever". 1994-1997 $ 225,000
-
Co-Investigator, United States-Israel Binational Science Foundation:"Genetic linkage study in Arthrogryposis Multiplex Congenita". 1994-1997 $ 105,000
-
Principal Investigator, Grant #RO1-DC02273 from the National Institute on Deafness and Other Communication Disorders: "Molecular basis of aminoglycoside induced ototoxicity". 1994-2000 $ 900,000
-
Principal Investigator, Grant #2 RO1-DC01402/05-07 from the National Institute on Deafness and Other Communication Disorders: "Molecular basis of maternally transmitted deafness". 1996-2001 $ 1,018,000
-
Co-Principal Investigator, Grant #RO1-DC-03395 from the National Institute on Deafness and Other Communication Disorders: "Mitochondrial DNA in aging human cochleas". 1997-2001 Funds for my laboratory: $ 500,000
-
Core director, GCRC supplement for genotyping/phenotyping core, NIH. 1999 - 2001 $ 1,011,968
-
Principal Investigator, Grant #RO1-DC04092 from the National Institute on Deafness and Other Communication Disorders: “Mitochondrial translation and hearing impairment”. 1999-2003 $ 1,171,000
-
Co-Investigator, Grant #RO1-DK54967 from the National Institute of Diabetes and Digestive and Kidney Diseases: “Mapping the genes for inflammatory bowel disease”. 1999-2004 $ 1,354,000
-
Co-Investigator, Grant #R01 DC05827-01A1 from the National Institute on Deafness and Other Communication Disorders: "Genetics ofAge-Related Hearing Loss". 2003-2006 $ 900,000
-
Principal Investigator, Grant #2 RO1-DC01402/08-11 from the National Institute on Deafness and Other Communication Disorders: "Molecular basis of maternally transmitted deafness". 2002-2007 $ 1,516,000
-
Principal Investigator, Grant #1RO1-DK074368 from the National Institute of Diabetes and Digestive and Kidney Diseases: "Mitochondrial Myopathy and Sideroblastic Anemia". 2006-2010 (no-cost extension since 2/2009) $1,165,000
DAFNA Capital Management LLC | 10990 Wilshire Boulevard, Suite 1400 | Los Angeles, CA 90024 | Contact Us | p: 310.954.3200
Please review our Disclaimers and Important Legal Information
© 2022, DAFNA Capital Management, LLC